Search results
Author(s):
Jeffrey Park
,
Hussam S Suradi
Added:
3 years ago
Heart failure (HF) is a major national and international pandemic with a prevalence of more than 5.8 million in the US and over 26 million worldwide. It is the leading cause of hospitalisation and healthcare costs in the US and it accounts for more than 1 million hospitalisations annually. In the US, up to 25% of patients hospitalised with HF are readmitted within 30 days.1 The financial burden…
View more
Author(s):
Andrea Mortara
,
Lucia Vaira
,
Vittorio Palmieri
,
et al
Added:
3 years ago
Innovative patient-centred interventions are required to improve the self-management of complex, costly and relapsing conditions, such as heart failure (HF). Mobile health (mHealth) technology is a promising tool that could potentially help us reach these goals, but evidence of its clinical benefits and the security of personal health information is still scarce. In view of the increasing number…
View more
Author(s):
Darshan H Brahmbhatt
,
Martin R Cowie
Added:
3 years ago
Heart failure (HF) is increasing in prevalence globally, and is associated with considerable ill health, healthcare costs and mortality. Prevalence increases steeply with age, and the average age of a person admitted to hospital with decompensation in developed countries such as the UK is in the high 70s.1 Comorbidity is the rule, with half of hospitalised patients having at least five…
View more
Author(s):
Cristiana Vitale
,
Ilaria Spoletini
,
Giuseppe Rosano
Added:
3 years ago
Exercise intolerance is a typical symptom of heart failure (HF), impairing patients’ ability to perform activities of daily living and affecting quality of life (QOL).1 Chronic HF is characterised by a progressive reduction in exercise capacity, increasing fatigue and shortness of breath.2 In addition, exercise intolerance is often accompanied by increased blood pressure and chronotropic…
View more
e-SPACE Heart Failure 2021
Video Series
Author(s):
Tomaz Podlesnikar
,
Victoria Delgado
,
Jeroen J Bax
Added:
3 years ago
Heart failure (HF) is a rapidly growing public health problem with an estimated prevalence of more than 26 million people worldwide.1 In developed countries the prevalence is 1–2% peaking at ≥10% among people aged over 70 years.2 In the US, the lifetime risk of developing HF is 20% among people aged 40 years or older.3 Diagnosing the underlying cause of HF is central to the choice of appropriate…
View more
THT 2024
Start date:
Mar 06, 2024
End date:
Mar 04, 2024
Event
Author(s):
Maria Rosa Costanzo
Added:
3 years ago
Approximately 90% of the more than 1 million yearly heart failure hospitalisations in the US and Europe are a result of symptoms and signs of fluid overload and are associated with readmission rates of 24% and 50% at 30 days and 6 months, respectively.1,2 Recurrent heart failure-related hospitalisations have uniformly been associated with worse outcomes, independent of age and renal function.3
…
View more
Author(s):
Rekha V Thammana
,
Sarah J Goodlin
Added:
1 year ago
Author(s):
Aliza Hussain
,
Arunima Misra
,
Biykem Bozkurt
Added:
2 years ago